A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes.
Influenza A virus (IAV) predisposes individuals to often more severe secondary bacterial infections with Streptococcus pneumonia (S. pneumoniae). The outcomes of these infections may be made worse with the increase in antimicrobial resistance and a lack of new treatments to combat this. Th17 respons...
Saved in:
Main Authors: | Paula T Maguire, Sinéad T Loughran, Ruth Harvey, Patricia A Johnson |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/126bb045368d4fa68f4b6426253b4b4b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contextualization procedure and modeling of monocyte specific TLR signaling.
by: Maike K Aurich, et al.
Published: (2012) -
Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease
by: Zhiming Wang, et al.
Published: (2020) -
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
by: Sathana Dushyanthen, et al.
Published: (2017) -
Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry
by: Takahiro Sawada, et al.
Published: (2021) -
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
by: Zhang,Li, et al.
Published: (2015)